Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers von Zelikson, Viktoriya, Gurumurthi, Ashwath, Sawalha, Yazeed, Annunzio, Kaitlin, Saha, Aditi, Dong, Ning, Qualls, David, Amoozgar, Behzad, Kahl, Brad, Baird, John, Challa, Pavan, Huntington, Scott F, Santos, Jennifer, Bair, Steven, Narkhede, Mayur, Li, Shuning, Frosch, Zachary, Ho, Carrie, Smith, Stephen D, Winter, Allison, Landsburg, Daniel, Furqan, Fateeha, Hamadani, Mehdi, Baird, Katelin, Romancik, Jason, Alharthy, Hanan, Law, Jennie, Bojanini, Leyla, Advani, Ranjana, Hu, Boyu, Johnson, Patrick Connor, Grover, Natalie S., Merril, Mwanasha, Crombie, Jennifer L., Shafagati, Nazila, Sterling, Cole, Nastoupil, Loretta J., Epperla, Narendranath, Ayers, Emily C

Volltext

Antibody-Based Therapies for Peripheral T-Cell Lymphoma von Shafagati, Nazila, Paul, Suman, Rozati, Sima, Sterling, Cole H

Volltext

Novel Single Agents Are Equivalent to Conventional Chemotherapy Inpatients with Relapsed and Refractory Mature T-Cell Lymphomas: A Meta-Analysis von Shafagati, Nazila, Stuver, Robert N., Boussi, Leora, Koh, Min Jung, Park, Allison, Bain, Paul, Foss, Francine M., Shen, Changyu, Jain, Salvia

Volltext

Loncastuximab in High-Risk and Heavily-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real World Analysis from 21 US Centers von Ayers, Emily, Zelikson, Viktoriya, Gurumurthi, Ashwath, Sawalha, Yazeed, Annunzio, Kaitlin, Saha, Aditi, Dong, Ning, Qualls, David Augustus, Amoozgar, Behzad, Kahl, Brad S., Baird, John H., Challa, Pavan, Huntington, Scott F., Santos, Jennifer, Bair, Steven M., Narkhede, Mayur S., Li, Shuning, Frosch, Zachary AK, Ho, Carrie I, Smith, Stephen D, Winter, Allison, Landsburg, Daniel J., Furqan, Fateeha, Hamadani, Mehdi, Baird, Katelin, Romancik, Jason T., Alharthy, Hanan, Law, Jennie, Bojanini, Leyla, Advani, Ranjana H., Hu, Boyu, Johnson, Patrick Connor, Grover, Natalie S., Kundu, Debamita, Merrill, Mwanasha Hamuza, Crombie, Jennifer L, Shafagati, Nazila, Sterling, Cole, Nastoupil, Loretta J., Epperla, Narendranath

Volltext

Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis von Shafagati, Nazila, Koh, Min J., Boussi, Leora, Park, Hyun J., Stuver, Robert, Bain, Paul, Foss, Francine M., Shen, Changyu, Jain, Salvia

Volltext